8/11/2019 Nucleon Q.5 Answer

1/4

8/11/2019 Nucleon Q.5 Answer

2/4

10 years downthe line: Longterm Strategyof Nucleon

Developing newpartnerships is an

important strategy for thecontinued growth andsuccess of Nucleon

Increasing theavailability of resources,expanding capabilities

and strengtheninginternal research and

development.

D

p

8/11/2019 Nucleon Q.5 Answer

3/4

Suggestions

Nucleon to base itsproduct pipeline on

the following criteria: There is an unmet

medical need

There is a chance toachieve a dominantproprietary positions

There arepredictablepreclinical models

The used technologyadds value

The cell lines can bescaled-up

Nucleon shouldevolve into an R&D

boutique with pilotscale manufacturingcapabilities.

The of ro

diveapplCRPwouin-hoof thand cells

8/11/2019 Nucleon Q.5 Answer

4/4

Focus on developing a mammalian cells technology, wh

developing biologics faster, easier, safer and more cost-than the conventional bacterial cells method.

Nucleon will have to continuously improve its innovattechnology; therefore it is necessary to build a pilot pladesigned to manufacture products using mammalian cefermentation;

This will give it a competitive advantage on the other cusing the traditional technology.